title: Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects.
abstract: von Hippel-Lindau (VHL) disease is an inherited multisystem familial cancer syndrome caused by mutations of the VHL gene on chromosome 3p25. A wide variety of neoplastic processes are known to be associated with VHL disease. The consequences of the VHL mutations and the pathway for tumor development continue to be elucidated. This paper will detail the variety of tumors associated with VHL disease and discuss the genetic mechanisms that lead to the predisposition for neoplasia.
authors.affiliation: Department of Pathology, Children's Healthcare of Atlanta, Egleston, Atlanta, GA 30322, USA. bshehat@emory.edu
authors.forename: Bahig M
authors.initials: BM
authors.lastname: Shehata
authors.forename: Christina A
authors.initials: CA
authors.lastname: Stockwell
authors.forename: Amilcar A
authors.initials: AA
authors.lastname: Castellano-Sanchez
authors.forename: Shannon
authors.initials: S
authors.lastname: Setzer
authors.forename: Christine L
authors.initials: CL
authors.lastname: Schmotzer
authors.forename: Haynes
authors.initials: H
authors.lastname: Robinson
mesh_terms: D020022:Genetic Predisposition to Disease; D018095:Germ-Line Mutation; D006801:Humans; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000235:genetics; D006623:von Hippel-Lindau Disease / Q000235:genetics* / Q000473:pathology*
chemical_list: D051794:Von Hippel-Lindau Tumor Suppressor Protein; C497446:VHL protein, human